PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Visit https://www.peervoice.com/KAN860 to view the entire programme with slides. After completing “Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors”, participants will be able to: Explain the most recent clinical evidence for SGLT2 inhibitors for the management of patients with heart failure (HF) and associated guidelines; Evaluate how these clinical data add to previous knowledge about the management of HF; Discuss the clinical implications of the guidelines and data in the context of current HF treatment paradigms.